Protalix BioTherapeutics to Announce First Quarter 2022 Financial and Business Results Conference Call on May 16, 2022

/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development, production and...

Related Keywords

United States ,Israel ,Brazil ,Carmiel ,Ha Afon ,American ,Chiesi Farmaceutici ,Chuck Padala ,Protalix Biotherapeutics Inc ,Prnewswire Protalix Biotherapeutics Inc ,Pfizer Inc ,Company Link ,Drug Administration ,Daylight Time ,Call Details ,Events Calendar ,Protalix Biotherapeutics ,Nc ,